z-logo
Premium
Patient‐derived sarcoma xenografts for individual‐patient selection of chemotherapy—ready for prime time?
Author(s) -
Wagner Andrew J.
Publication year - 2014
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.28694
Subject(s) - medicine , sarcoma , chemotherapy , selection (genetic algorithm) , oncology , pathology , artificial intelligence , computer science
Patient‐derived sarcoma tumor xenografts can be successfully grown in mice and tested for sensitivity to chemotherapy regimens. Are these tests ready to guide patient care?

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here